Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.

Research paper by G G Lupattelli, A R AR Roscini, D D Siepi, E E Mannarino

Indexed on: 14 Sep '10Published on: 14 Sep '10Published in: Journal of Clinical Pharmacy and Therapeutics


This case report presents the clinical history of a patient with elevated lipoprotein(a) and small size isoform, associated with mixed hyperlipaemia, which was probably familial combined hyperlipaemia. After premature myocardial infarction, the subject was treated with fibrates. Niacin was started after recurrence. One year ago, after another episode of acute coronary syndrome, rosuvastatin was added to niacin. The atherogenicity of this lipid disorder, along with the different options for therapy is discussed.